abrdn plc Has $85.87 Million Stock Holdings in The Clorox Company (NYSE:CLX)

abrdn plc reduced its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 5.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 531,871 shares of the company’s stock after selling 28,843 shares during the quarter. abrdn plc owned 0.43% of Clorox worth $85,873,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Brooklyn Investment Group boosted its stake in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC purchased a new position in shares of Clorox during the third quarter valued at approximately $27,000. Continuum Advisory LLC grew its holdings in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC purchased a new stake in Clorox in the 3rd quarter valued at $48,000. Finally, Friedenthal Financial bought a new position in Clorox during the 3rd quarter valued at $49,000. 78.53% of the stock is owned by institutional investors.

Clorox Stock Down 7.2 %

Shares of NYSE CLX opened at $148.29 on Wednesday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market capitalization of $18.36 billion, a PE ratio of 51.67, a P/E/G ratio of 2.92 and a beta of 0.42. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The business’s fifty day moving average price is $162.63 and its 200-day moving average price is $158.67.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same quarter in the prior year, the firm earned $2.16 EPS. On average, equities research analysts anticipate that The Clorox Company will post 6.86 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. Clorox’s payout ratio is 170.04%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Barclays reduced their target price on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday. Wells Fargo & Company lifted their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Finally, DA Davidson lifted their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $157.64.

Get Our Latest Stock Report on CLX

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.